News Ireland to get 300 Regeneron jobs in $300m manufacturing boost Rebecca 0 Comment Some 300 pharmaceutical manufacturing jobs are to be created over three years in Limerick, Ireland, by Regeneron, the Share X Ireland to get 300 Regeneron jobs in $300m manufacturing boost https://pharmaphorum.com/news/ireland-to-get-300-regeneron-jobs-in-300m-manufacturing-boost/
News Influential MSD figure appeals to governments on behalf of pharma Claire 0 Comment Merck Sharp & Dohme’s president responsible for business in Europe and Canada has called on governments to see Share X Influential MSD figure appeals to governments on behalf of pharma https://pharmaphorum.com/news/influential-msd-figure-appeals-to-governments-on-behalf-of-pharma/
News HCV antivirals are new target for humanitarian prices Claire 0 Comment The director-general of the World Health Organization (WHO), Margaret Chan, has told Reuters that hepatitis C is the Share X HCV antivirals are new target for humanitarian prices https://pharmaphorum.com/news/hcv-antivirals-are-new-target-for-humanitarian-prices/
News Valeant buys cosmetic surgery devices company for $250 million Rebecca 0 Comment Valeant Pharmaceuticals is seeking to strengthen its cosmetics business with an agreement to buy Solta Medical for about Share X Valeant buys cosmetic surgery devices company for $250 million https://pharmaphorum.com/news/valeant-buys-cosmetic-surgery-devices-company-for-250-million/
News GlaxoSmithKline to spend a billion raising its stake in India Rebecca 0 Comment GlaxoSmithKline is to pay £629 million (64 billion Indian rupee and about one billion US dollars) in raising Share X GlaxoSmithKline to spend a billion raising its stake in India https://pharmaphorum.com/news/glaxosmithkline-to-spend-a-billion-raising-its-stake-in-india/
News ‘Low but stable’ pharma growth in 2014 Rebecca 0 Comment The ratings agency Fitch has said in its 2014 outlook report for global branded pharmaceuticals that it forecasts Share X ‘Low but stable’ pharma growth in 2014 https://pharmaphorum.com/news/low-but-stable-pharma-growth-in-2014/
News First-in-class diabetes drug recommended for FDA approval Rebecca Diabetes, FDA approvals 2013, Forxiga 0 Comment AstraZeneca and Bristol-Myers Squibb have received a positive opinion from an FDA committee for dapagliflozin, a sodium-glucose cotransporter Share X First-in-class diabetes drug recommended for FDA approval https://pharmaphorum.com/news/first-in-class-diabetes-drug-recommended-for-fda-approval/
News Female sexual dysfunction company to keep fighting for its pill Rebecca 0 Comment Having taken on the development of flibanserin from Boehringer Ingelheim and put the drug for a problem with Share X Female sexual dysfunction company to keep fighting for its pill https://pharmaphorum.com/news/female-sexual-dysfunction-company-to-keep-fighting-for-its-pill/
News Cognitive effects of antidepressant buoy Lundbeck Rebecca 0 Comment Lundbeck has risen to a two-year high on the markets after announcing the cognitive results of a trial Share X Cognitive effects of antidepressant buoy Lundbeck https://pharmaphorum.com/news/cognitive-effects-of-antidepressant-buoy-lundbeck/
